Remyelination protects neurons from DLK-mediated neurodegeneration

Area of Science:

• Neuroscience
• Cell Biology
• Pathology

Background:

• Chronic demyelination and oligodendrocyte loss impair neuronal function.
• Neuron and connection degeneration drive progressive disability in demyelinating diseases.
• The link between chronic demyelination and neurodegeneration is not fully understood.

Purpose of the Study:

• To investigate whether chronic demyelination triggers neurodegeneration.
• To elucidate the mechanisms by which chronic demyelination may cause neurodegeneration.
• To evaluate the neuroprotective potential of remyelination and identify therapeutic targets.

Main Methods:

• Characterization of two inducible genetic mouse models of demyelination with differing remyelination capacities.
• Assessment of axonal damage, neuronal apoptosis, microglial inflammation, and functional recovery.
• Analysis of kinase activation, including dual leucine zipper kinase (DLK) and c-Jun phosphorylation.
• Pharmacological and genetic inhibition of DLK.

Main Results:

• Both demyelinating models showed axonal damage.
• Mice with failed remyelination exhibited increased neuronal apoptosis and altered microglial inflammation.
• Mice with successful remyelination showed no neuronal apoptosis and improved functional recovery.
• Remyelination-incapable mice displayed increased DLK pathway activation and c-Jun phosphorylation.
• DLK inhibition blocked c-Jun phosphorylation and neuronal apoptosis.

Conclusions:

• Remyelination is intrinsically neuroprotective in the context of chronic demyelination.
• The DLK signaling pathway is a key mediator of neuronal apoptosis in demyelinated neurons.
• DLK inhibition represents a promising therapeutic strategy for protecting neurons in chronic demyelinating diseases.